Timeline

Jeanne Chiaravalli
Research Engineer
10 Sep 2024
publication

High Content Screening Assay of Inhibitors of the Legionella pneumophila Histone Methyltransferase RomA in Infected Cells.

Read more
21 Jun 2024
publication

High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors.

Read more
21 Apr 2023
publication

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.

Read more
22 Mar 2023
publication

Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors.

Read more
04 Jul 2022
publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Read more
17 Jun 2022
news

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Read more
01 May 2022
publication

A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.

Read more
21 Sep 2021
publication

Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.

Read more
01 Sep 2021
publication

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.

Read more
25 May 2021
publication

Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues.

Read more
05 Jun 2015
team

Chemogenomic and Biological Screening Platform (PF-CCB)

Read more